PPMSEQ
LIVE

Serial Number

98314914

Owner

Ultima Genomics, Inc.

Attorney

Sheila Fox Morrison

Filing Date

Dec 14, 2023

Add to watchlist:

No watchlists yet
View on USPTO

PPMSEQ Trademark

Serial Number: 98314914

PPMSEQ is a trademark filed by Ultima Genomics, Inc. on December 14, 2023. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 42 (Computer & Scientific). The application is currently pending registration.

Owner Contact Info

Ultima Genomics, Inc. (10 trademarks)

4209 Technology Drive
Fremont, CA 94538

Entity Type: 03

Trademark Details

Filing Date

December 14, 2023

Registration Date

Not Registered

Published for Opposition

September 17, 2024

Goods & Services

downloadable computer software for database management and for storage of electronic data; downloadable computer software for creating searchable databases of information and data; downloadable computer software for use in managing databases in the field of nucleic acid sequencing, genotyping, diagnostics, diagnostic research, clinical research, drug development, pharmaceuticals, laboratory research, scientific research, medical research, life sciences, biology, microbiology, metagenomics, biotechnology, genetic testing, and genetics; downloadable computer software for use in conducting medical and scientific research services in the field of genotyping, diagnostics, molecular pathology, molecular diagnostics, laboratory medicine, and oncology; downloadable computer software for use in conducting DNA sequencing, screening, and analysis services for medical and scientific research purposes; downloadable computer software for use in conducting nucleic acid sequencing, screening, and analysis services for medical and scientific research purposes; downloadable computer software for use in conducting genomic sequencing, screening, and analysis services for medical research purposes; downloadable computer software for use in conducting genetic analysis and reporting services for medical and scientific research purposes; downloadable computer software for use in managing next-generation sequencing (NGS) bioinformatics data processor in the fields of nucleic acid sequencing, genotyping, genetic testing, and genetics; downloadable computer software for compressing and decompressing genomic data files; downloadable computer software, namely, software to receive and store DNA, RNA and genetic records, and to authorize medical and research personnel to use records.

Reagents, assays, enzymes, nucleotides, and buffers for medical use; diagnostic agents, reagents, preparations, and substances for medical use; kits containing reagents and a printed instructional protocol manual for use thereof for medical purposes, sold as a unit; kits comprising nucleotides, reagents, enzymes, agents, assays, buffers, or diagnostic preparations for medical genetic testing and medical diagnostic purposes; reagents, assays, enzymes, nucleotides, buffers, and diagnostic agents and preparations for medical purposes in the fields of nucleic acid sequencing, genotyping, diagnostics, metagenomics, genetic testing, and genetics.

Biological agents, chemical agents, reagents, assays, enzymes, nucleotides, buffers, chemical preparations, and biological preparations for medical research and scientific research use; diagnostic reagents and preparations for medical research and scientific research; kits containing reagents and a protocol for use thereof for medical research and scientific purposes; biological agents, chemical agents, reagents, assays, enzymes, nucleotides, buffers, chemical preparations, and biological preparations for scientific and research use in the fields of nucleic acid sequencing, genotyping, diagnostics, diagnostic research, clinical research, drug development, pharmaceuticals, laboratory research, scientific research, medical research, life sciences, biology, microbiology, metagenomics, biotechnology, agriculture, forensics, food safety, genetic testing, and genetics; kits comprising nucleotides, reagents, enzymes, agents, assays, buffers, chemical preparations, or biological preparations for scientific and research use in the fields of nucleic acid sequencing, genotyping, diagnostics, diagnostic research, clinical research, drug development, pharmaceuticals, laboratory research, scientific research, medical research, life sciences, biology, microbiology, metagenomics, biotechnology, genetic testing, and genetics.

Medical and scientific research in the field of genome sequence analysis and reporting; DNA screening for medical and scientific research purposes; clinical laboratory services in preparing, amplifying, labeling, detecting, analyzing, and sequencing nucleic acids and other biological molecules from human beings or animals for scientific and medical research purposes; scientific consulting and research services and clinical laboratory testing services in the fields of amplification, detection, sequencing, and analysis of nucleic acids and the preparation of nucleic acid libraries; nucleic acid sequencing services for medical and scientific research purposes; providing temporary use of non-downloadable computer software for scientific analysis of genetic sequences; providing temporary use of non-downloadable computer software for storing, organizing, and creating a searchable library of genetic data for use in sequence detection, and disease detection and diagnosis; providing temporary use of non-downloadable computer software for database management and for storage of electronic data; providing temporary use of non-downloadable computer software for creating searchable databases of information and data; providing temporary use of non-downloadable computer software for use in managing databases in the field of nucleic acid sequencing, genotyping, diagnostics, diagnostic research, clinical research, drug development, pharmaceuticals, laboratory research, scientific research, medical research, life sciences, biology, microbiology, metagenomics, biotechnology, genetic testing, and genetics; providing temporary use of non-downloadable computer software for use in conducting medical research in the field of genotyping, diagnostics, molecular pathology, molecular diagnostics, laboratory medicine, and oncology; providing temporary use of non-downloadable computer software for use in conducting DNA sequencing, screening, and analysis for medical and scientific research purposes; providing temporary use of non-downloadable computer software for use in conducting nucleic acid sequencing, screening, and analysis for medical and scientific research purposes; providing temporary use of non-downloadable computer software for use in conducting genomic sequencing, screening, and analysis for medical and scientific research purposes; providing temporary use of non-downloadable computer software for use in conducting genetic analysis and reporting for medical and scientific research purposes; providing temporary use of non-downloadable computer software for use in managing next-generation sequencing (NGS) bioinformatics data processor in the fields of nucleic acid sequencing, genotyping, genetic testing, and genetics; providing temporary use of non-downloadable computer software for compressing and decompressing genomic data files; providing temporary use of non-downloadable computer software, namely, software to receive and store DNA, RNA and genetic records, and to authorize medical and research personnel to use records.

Filing History

TEAS CHANGE OF CORRESPONDENCE RECEIVED
Dec 17, 2024 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Dec 17, 2024 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Dec 17, 2024 REAP
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Nov 12, 2024 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Sep 17, 2024 NPUB
PUBLISHED FOR OPPOSITION
Sep 17, 2024 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Aug 28, 2024 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Aug 13, 2024 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Aug 13, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 12, 2024 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Aug 12, 2024 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jul 17, 2024 GNRN
NON-FINAL ACTION E-MAILED
Jul 17, 2024 GNRT
NON-FINAL ACTION WRITTEN
Jul 17, 2024 CNRT
ASSIGNED TO EXAMINER
Jul 15, 2024 DOCK
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jul 2, 2024 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jul 2, 2024 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jul 2, 2024 REAP
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jun 12, 2024 NWOS
TEAS AMENDMENT ENTERED BEFORE ATTORNEY ASSIGNED
Jun 12, 2024 TAEA
TEAS VOLUNTARY AMENDMENT RECEIVED
Jun 12, 2024 PARI
NEW APPLICATION ENTERED
Dec 14, 2023 NWAP